E-cadherin has been shown to play an important role in liver cancer including early hepatocellular carcinoma recurrence after surgery32, enhancing cell invasion and migration33, promoting intrahepatic metastasis34 and extrahepatic metastasis35, and its expression has also been demonstrated as a potential prognostic marker36–38. This evidence concerns the gene CDH1 and liver cancer.